Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2003
12/30/2003US6670128 Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies
12/30/2003US6670127 Method for assembly of a polynucleotide encoding a target polypeptide
12/30/2003US6670126 Poly-primed amplification of nucleic acid sequences
12/30/2003US6670121 Methods for characterizing mRNA molecules
12/30/2003US6669963 Stable particle in liquid formulations
12/30/2003US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes
12/30/2003US6669943 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/30/2003US6669942 Defective adenoviruses having a genome that includes a first recombinant DNA containing a therapeutic gene and a second rcombinant DNA containing an immunoprotective gene
12/30/2003US6669941 Administering drugs comprising tumor necrosis factor adrenergic blocking agents conjugated to immunoglobulins for the prophylaxis of rheumatoid arthritis, multiple sclerosis or diabetes
12/30/2003US6669936 Gene therapy
12/30/2003US6669935 Transducing endothelial cells of arteries in brain, with genetic vectors including polynucleotides which code for cytolysis drugs; gene therapy; drug delivery
12/30/2003US6669934 Administering interleukins, cytokines, leukemia inhibitory factors, ciliary neurotrophic growth factors, oncostatins and derivatives to mammals to control pregnancy
12/30/2003CA2380690C Human osteoclast-derived cathepsin
12/30/2003CA2317314C Animal nutrition compositions
12/30/2003CA2296070C Novel mapk kinase
12/30/2003CA2241923C Receptor-mediated gene transfer system for targeting tumor gene therapy
12/30/2003CA2172248C Self-sustained sequence replication electrochemiluminescent nucleic acid assay
12/30/2003CA2163641C Multiple sclerosis virus
12/30/2003CA2132976C Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
12/30/2003CA2128421C Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
12/30/2003CA2121358C Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis
12/30/2003CA2075549C A promoter screening vector, streptomyces promoters found therewith, and the isolation and use thereof
12/30/2003CA2067862C Stable pura vectors and uses thereof
12/25/2003WO2003106682A1 Hla-a24-restricted cancer antigen peptide
12/25/2003WO2003106641A2 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid
12/25/2003WO2003106497A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer
12/25/2003WO2003106495A2 MONOCLONAL ANTIBODY hPAM4
12/25/2003US20030237117 High velocity projectile bombardment; insect resistant plants
12/25/2003US20030237112 Nuclear fertility restorer genes and methods of use in plants
12/25/2003US20030237111 Lepidopteran-active Bacillus thuringiensis delta-endotoxin polynucleotides, compositions, and methods of use
12/25/2003US20030237110 Polynucleotides and polypeptides derived from corn seedling
12/25/2003US20030237109 Flower-bud formation suppressor gene and early flowering plant
12/25/2003US20030237108 Compositions isolated from forage grasses and methods for their use
12/25/2003US20030237107 Nucleotide sequences; transfer cassettes; controlling gene expression; insertion of transfer cassettes
12/25/2003US20030237106 Transgenic animal containing CD200 and uses therefor
12/25/2003US20030237105 Transgenic hybrid rodents; modulation phenotype
12/25/2003US20030237104 Methods for developing animal models
12/25/2003US20030237103 Methods and compositions for pharmacological and toxicological evaluation of test agents
12/25/2003US20030237102 Method of reducing neuronal electrical activity with a potassium channel subunit
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030236629 Method and apparatus for calculating optimized solution of amino acid sequences of multiple-mutated proteins and storage medium storing program for executing the method
12/25/2003US20030236394 Light activated gene transduction using long wavelength ultraviolet light for cell targeted gene delivery
12/25/2003US20030236392 Genetic engineering; polypeptide library
12/25/2003US20030236390 Materials for the production of nanometer structures and use thereof
12/25/2003US20030236389 Proteins, polynucleotides encoding them and methods of using the same
12/25/2003US20030236209 Compositions and methods for the therapy and diagnosis of lung cancer
12/25/2003US20030236208 Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides
12/25/2003US20030236207 Particulate complex for administering nucleic acid into a cell
12/25/2003US20030236206 Diagnosis of disease; screening antibodies
12/25/2003US20030236204 Antisense modulation of histone deacetylase 2 expression
12/25/2003US20030236195 Isolated from Bacillus; for controlling Lepidotera
12/25/2003US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2
12/25/2003US20030235916 Cationic with cationic surfactant
12/25/2003US20030235913 Hybrid nucleic acid; screening antibodies
12/25/2003US20030235912 Screening antibodies; cardiovascular disorders; gastrointestinal disorders
12/25/2003US20030235911 Hybrid nucleic acid
12/25/2003US20030235910 Antisense modulation of G protein-coupled receptor 49 expression
12/25/2003US20030235901 Detoxification using amylase; drug screening analysis
12/25/2003US20030235900 Anticancer agents
12/25/2003US20030235899 Catalytic domain of the human effector cell cycle checkpoint protein kinase Chk1 materials and methods for identification of inhibitors thereof
12/25/2003US20030235892 From genetic engineered Dna expression vector
12/25/2003US20030235890 Antiinflammatory agents; oral diseases; Alzheimer's disease; nucleic acid with detectable label
12/25/2003US20030235889 Materials and methods involving conditional retention domains
12/25/2003US20030235888 Therapy for bone defects
12/25/2003US20030235886 Nucleotide sequences; genetic engineering; controller fusion protein; blocking transcription
12/25/2003US20030235884 Hybrid protein; process control; glycosylation
12/25/2003US20030235882 Genetic engineered polypeptides; binding to antibodies
12/25/2003US20030235880 Genetic engineered nucleic acid
12/25/2003US20030235869 Biological products
12/25/2003US20030235864 Method to screen ligands using eukaryotic cell display
12/25/2003US20030235857 Regulation of fungal gene expression
12/25/2003US20030235854 Methods for analyzing a nucleic acid
12/25/2003US20030235852 Nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues, and methods of making same using peptide modifying agents
12/25/2003US20030235851 Fusion proteins; combinatorial libraries
12/25/2003US20030235850 Method for in vivo identification of intracellular epitopes
12/25/2003US20030235849 Using rolling circle replication to propagate preferential nucleotide sequences; strand displacement amplification; DNA sequencing
12/25/2003US20030235845 Directing splicing of messenger RNA associated with dystrophin protein for diagnosis and treatment of muscular dystrophy
12/25/2003US20030235842 Map
12/25/2003US20030235841 Identifying allelic mutations associate with nervous system disorders; restriction fragment length polymorphisms
12/25/2003US20030235839 Separating genomic nucleotide sequences from low molecular weight structures such as plasmids in cells; high throughput assay
12/25/2003US20030235838 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
12/25/2003US20030235837 Comprises probes and primers for classifying parasitic microorganisms; restriction fragment length polymorphisms; variable number of tandem repeat sequences
12/25/2003US20030235836 Labeling of objects to be identified consisting of at least one DNA fragment
12/25/2003US20030235830 Partitioning endogenous cellular transcription products and associated proteins for generating gene expression profile of cells
12/25/2003US20030235827 Methods and compositions for monitoring primer extension and polymorphism detection reactions
12/25/2003US20030235824 Antireflective coatings for high-resolution photolithographic synthesis of DNA array
12/25/2003US20030235822 Computer software for mismatch discrimination based on thermodynamics
12/25/2003US20030235820 Detecting and identifying tumor related transcripts associated with cancer; screening and monitoring antiproliferative agents
12/25/2003US20030235814 Expression vector which uses homologous recombination and a two hybrid system to transfer and clone heterologous nucleotide sequences
12/25/2003US20030235812 Diagnosing diabetic disorders via impaired insulin secretion, decreased adenine triphosphate biosynthesis and increased levels of reactive oxygen species
12/25/2003US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof
12/25/2003US20030235591 Comprises hepatitis B surface antigens
12/25/2003US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation
12/25/2003US20030235584 Method for preparing anti-MIF antibodies
12/25/2003US20030235582 Anti-IGF-I receptor antibody
12/25/2003US20030235580 Reconstituted and recombinant tissue membranes and methods for pharmaceutical delivery of bioactive molecules
12/25/2003US20030235579 Anti-equine Fc epsilon receptor alpha chain antibodies and method to detect IgE
12/25/2003US20030235572 Human GDP-mannose 4,6 dehydratase
12/25/2003US20030235557 Administering two viral vectors containing an immunogenic portion of a wilms' tumor (wt1) polynucleotide operably linked to an expression control sequence
12/25/2003US20030235535 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions
1 ... 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 ... 4023